Synthego is a leading provider of genome engineering solutions. Our flagship product, CRISPRevolution, is a portfolio of synthetic guide RNA designed for CRISPR genome editing and research. Synthego’s vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist.
For more information, visit
www.synthego.com and follow us on www:twitter.com/synthego
Founder: Michael Dabrowski and Alex Pesch
CEO: Paul Dabrowski
Please click here for Synthego job opportunities.